Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
HSIC 
Henry Schein Inc (HSIC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/13/2025: HSIC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
16 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Year Target Price $76.35
Year Target Price $76.35
| 3 | Strong Buy |
| 4 | Buy |
| 8 | Hold |
| 0 | Under performing |
| 1 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit -24.74% | Avg. Invested days 35 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/13/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.16B USD | Price to earnings Ratio 22.83 | 1Y Target Price 76.35 |
Price to earnings Ratio 22.83 | 1Y Target Price 76.35 | ||
Volume (30-day avg) 16 | Beta 0.87 | 52 Weeks Range 60.56 - 82.49 | Updated Date 06/30/2025 |
52 Weeks Range 60.56 - 82.49 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.21 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.21% | Operating Margin (TTM) 5.75% |
Management Effectiveness
Return on Assets (TTM) 4.61% | Return on Equity (TTM) 8.47% |
Valuation
Trailing PE 22.83 | Forward PE 15.24 | Enterprise Value 12254844175 | Price to Sales(TTM) 0.72 |
Enterprise Value 12254844175 | Price to Sales(TTM) 0.72 | ||
Enterprise Value to Revenue 0.97 | Enterprise Value to EBITDA 13.11 | Shares Outstanding 125005000 | Shares Floating 104277135 |
Shares Outstanding 125005000 | Shares Floating 104277135 | ||
Percent Insiders 0.84 | Percent Institutions 107.89 |
Analyst Ratings
Rating 4 | Target Price 76.35 | Buy 4 | Strong Buy 3 |
Buy 4 | Strong Buy 3 | ||
Hold 8 | Sell - | Strong Sell 1 | |
Strong Sell 1 |
Upturn AI SWOT
Henry Schein Inc
Company Overview
History and Background
Henry Schein, Inc. was founded in 1932. Initially a pharmacy in Queens, New York, it evolved into a distributor of healthcare products and services, focusing on dental, animal health, and medical markets. The company has grown through organic expansion and strategic acquisitions.
Core Business Areas
- Dental: Distribution of dental products, equipment, and services to dental practitioners, laboratories, and institutions globally.
- Animal Health: Distribution of animal health products, equipment, and services to veterinarians.
- Medical: Distribution of medical products to physician practices, hospitals, and other healthcare providers.
- Technology and Value-Added Services: Offers a range of technology solutions and value-added services, including practice management software, e-commerce platforms, and financial services.
Leadership and Structure
Stanley M. Bergman serves as the Chairman of the Board and Chief Executive Officer. The company has a structured executive leadership team overseeing various business segments and corporate functions. The organizational structure includes global sales, marketing, operations, and finance divisions.
Top Products and Market Share
Key Offerings
- Dental Consumables: Includes a wide range of everyday dental supplies, such as anesthetics, restoratives, and infection control products. Market share data not publicly available, but Henry Schein is a leading distributor. Competitors: Patterson Dental, Benco Dental.
- Dental Equipment: Includes dental chairs, X-ray machines, and CAD/CAM systems. Market share data not publicly available, but Henry Schein is a major player. Competitors: Planmeca, Dentsply Sirona.
- Animal Health Pharmaceuticals: Includes vaccines, antibiotics, and parasiticides. Market share data not publicly available but Henry Schein is a leading distributor. Competitors: MWI Animal Health (AmerisourceBergen), Patterson Veterinary.
- Practice Management Software: Includes software for appointment scheduling, patient records, and billing. Revenue from this product is not publicly available. Competitors: Carestream Dental, Patterson Dental.
Market Dynamics
Industry Overview
The healthcare distribution industry is characterized by consolidation, technological advancements, and increasing demand for cost-effective solutions. Factors like aging populations and rising healthcare expenditures drive growth. The animal health market is growing with increased pet ownership and spending on pet care.
Positioning
Henry Schein is a leading global distributor of healthcare products and services, positioned to capitalize on industry growth and consolidation. Its competitive advantages include its broad product portfolio, extensive distribution network, and strong customer relationships.
Total Addressable Market (TAM)
The global healthcare distribution market is estimated to be in the hundreds of billions of dollars. Henry Schein's positioning allows it to capture a significant share of this TAM across its dental, animal health, and medical segments.
Upturn SWOT Analysis
Strengths
- Global distribution network
- Diverse product portfolio
- Strong customer relationships
- Established brand reputation
- Extensive experience in healthcare distribution
Weaknesses
- Dependence on suppliers
- Exposure to economic cycles
- Competition in a fragmented market
- Vulnerability to cybersecurity threats
- Potential impacts from changes in healthcare regulations
Opportunities
- Expansion into emerging markets
- Acquisitions of smaller distributors
- Development of new technology solutions
- Increased demand for veterinary services
- Growth in dental implant and cosmetic dentistry markets
Threats
- Intense price competition
- Disruptions from online retailers
- Changes in healthcare reimbursement policies
- Economic downturns
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- Patterson Companies (PDCO)
- Dentsply Sirona (XRAY)
- AmerisourceBergen (ABC)
Competitive Landscape
Henry Schein benefits from its comprehensive offerings and global presence. Competitors like Patterson focus on specific segments, while others like Dentsply Sirona compete in equipment manufacturing. Henry Scheinu2019s distribution expertise provides an advantage.
Major Acquisitions
DDScapes
- Year: 2016
- Acquisition Price (USD millions): 83
- Strategic Rationale: Strengthened Henry Schein's digital dental technology portfolio.
Vets First Choice
- Year: 2019
- Acquisition Price (USD millions): 0
- Strategic Rationale: Merged Vets First Choice with Henry Schein Animal Health to form Covetrus (CVET). Henry Schein retained minority ownership.
Growth Trajectory and Initiatives
Historical Growth: Henry Schein has demonstrated consistent growth through organic expansion and strategic acquisitions. This growth requires analysis of past financial data.
Future Projections: Analyst estimates project continued growth for Henry Schein, driven by industry trends and strategic initiatives. These projections vary and should be sourced from reputable financial analysts.
Recent Initiatives: Recent strategic initiatives include investments in technology, expansion into new markets, and acquisitions of complementary businesses.
Summary
Henry Schein is a strong player in the healthcare distribution market, benefiting from its global presence and diverse product portfolio. Its established brand and distribution network are key strengths. Competition and potential economic downturns pose challenges. Recent strategic initiatives, particularly in technology, position it for continued growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports
- Financial news sources
- Analyst reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market data and analyst estimates are subject to change. Investment decisions should be based on individual research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Henry Schein Inc
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1995-11-03 | Executive Chairman & CEO Mr. Stanley M. Bergman CPA | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 25000 | Website https://www.henryschein.com |
Full time employees 25000 | Website https://www.henryschein.com | ||
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.